Marcos Barrouin Melo

An Oral Formulation of Angiotensin-(1-7) Produces Cardioprotective Effects in Infarcted and Isoproterenol-Treated Rats

Fúlvia D. Marques, Anderson J. Ferreira, Rubén D. Sinisterra et al. · Hypertension · 2011 · 142 citations · Full text

Succinate causes pathological cardiomyocyte hypertrophy through GPR91 activation

Carla Aguiar, João A Rocha-Franco, Pedro A. Sousa et al. · Cell Communication and Signaling · 2014 · 133 citations · Full text

Cholinergic Signaling Exerts Protective Effects in Models of Sympathetic Hyperactivity-Induced Cardiac Dysfunction

Mariana Gavioli, Aline Lara, Pedro Almeida et al. · PLoS ONE · 2014 · 93 citations · Full text

Cardiac Muscle, Heart Failure, Synaptic Transmission +24

Oral administration of an angiotensin-converting enzyme 2 activator ameliorates diabetes-induced cardiac dysfunction

Tatiane M. Murça, Patrícia L. Moraes, C.A. Capuruço et al. · Regulatory Peptides · 2012 · 73 citations · Full text

Hypertension, Heart Failure, Diabetes Management +13

Genetic deletion of the alamandine receptor MRGD leads to dilated cardiomyopathy in mice

Aline C. Oliveira, Marcos Barrouin Melo, Daisy Motta‐Santos et al. · American Journal of Physiology-Heart and Circulatory Physiology · 2018 · 71 citations

Molecular Pharmacology, Cardiomyopathy, Heart Failure +14